| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9726 |
| Human Intestinal Absorption | HIA+ | 0.9873 |
| Caco-2 Permeability | Caco2+ | 0.5851 |
| P-glycoprotein Substrate | Non-substrate | 0.7339 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7870 |
| Non-inhibitor | 0.9193 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9216 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8543 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8747 |
| CYP450 2D6 Substrate | Non-substrate | 0.9162 |
| CYP450 3A4 Substrate | Non-substrate | 0.7108 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8533 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9329 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9516 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8897 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9785 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9132 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9711 |
| Non-inhibitor | 0.9755 |
| AMES Toxicity | Non AMES toxic | 0.9369 |
| Carcinogens | Carcinogens | 0.6352 |
| Fish Toxicity | High FHMT | 0.6128 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8804 |
| Honey Bee Toxicity | High HBT | 0.8213 |
| Biodegradation | Ready biodegradable | 0.8885 |
| Acute Oral Toxicity | III | 0.8004 |
| Carcinogenicity (Three-class) | Non-required | 0.7128 |